# Generalized Neuro Biomarker Ontology Categorization (Neuromarker)

## Overview
**Neuromarker** expands the **Common Alzheimer’s Disease Research Ontology (CADRO)** into a **cross-disease biomarker categorization framework** applicable to **all neurodegenerative diseases (NDDs)**. It supports **multi-modal biomarker classification, AI integration, and cross-disease harmonization** for research and clinical applications.

## Core Biomarker Categories
Neuromarker retains **core CADRO categories** while expanding them to **disease-agnostic markers** for neurodegeneration.

| **Category**                  | **Description** |
|--------------------------------|----------------|
| **Molecular Biomarkers**       | Omics-based markers (genomic, transcriptomic, proteomic, metabolomic, lipidomic) |
| **Neuroimaging Biomarkers**    | Structural (MRI, CT), Functional (fMRI, PET), Molecular Imaging (tau, amyloid, α-synuclein) |
| **Fluid Biomarkers**           | CSF, plasma, blood-based markers for tau, amyloid, α-synuclein, TDP-43, GFAP, NfL |
| **Neurophysiological Biomarkers** | EEG, MEG, evoked potentials (ERP), sleep-related markers |
| **Digital Biomarkers**         | Gait analysis, cognitive/speech biomarkers, wearables data, EHR-based markers |
| **Clinical Phenotypic Markers** | Standardized clinical scores (MMSE, MoCA, CDR, UPDRS, ALSFRS, UHDRS) |
| **Genetic Biomarkers**         | Risk alleles (APOE, LRRK2, MAPT, C9orf72, PRNP) and polygenic risk scores |
| **Environmental & Lifestyle Factors** | Toxins, infections, diet, microbiome, comorbidities |

## Multi-Omics Integration for Neurodegenerative Diseases
Neurodegenerative diseases share **pathophysiological overlaps** but have **distinct molecular and imaging signatures**. **Neuromarker** enables:

- **Cross-disease biomarker comparison** (e.g., TDP-43 in FTD vs. ALS, α-synuclein in PD vs. MSA).
- **Molecular subtype classification** (e.g., tauopathies, synucleinopathies).
- **Temporal biomarker progression tracking** (early vs. late-stage disease changes).

### **Example: CSF Biomarkers in Multiple Diseases**
| **Biomarker**  | **AD** | **PD** | **FTD** | **ALS** | **HD** | **Prion** |
|---------------|--------|--------|--------|--------|--------|--------|
| **Amyloid-β** | High | Low | Variable | Normal | Normal | Normal |
| **Tau (total/p-tau)** | High | Variable | Variable | Normal | Normal | High |
| **α-Synuclein** | Normal | High | Normal | Normal | Normal | Normal |
| **NfL (Neurofilament Light Chain)** | High | High | High | High | High | High |
| **TDP-43** | Normal | Normal | High | High | Normal | Normal |

## AI-Assisted Biomarker Categorization
To support **AI-driven biomarker classification**, Neuromarker integrates:

| **Model Type** | **Application** |
|--------------|----------------|
| **Graph Neural Networks (GNNs)** | Identify shared biomarker pathways across diseases |
| **Contrastive Learning** | Distinguish overlapping vs. unique biomarkers |
| **Multimodal Transformer Models** | Integrate imaging, omics, and clinical data |

## Cross-Disease Harmonization & Ontology Standardization
To ensure **multi-disease compatibility**, Neuromarker aligns with **international ontologies**:

- **UMLS** (Unified Medical Language System)
- **MeSH** (Medical Subject Headings)
- **SNOMED-CT** (Systematized Nomenclature of Medicine)
- **HPO** (Human Phenotype Ontology)

## Real-World Integration with Open Datasets
Neuromarker is designed to integrate **multi-cohort, multi-disease datasets**:

| **Dataset**        | **Disease Area** | **Data Type** | **Access** |
|------------------|---------------|----------------|------------|
| **ADNI**        | AD            | Imaging, CSF, clinical | [ADNI](https://adni.loni.usc.edu) |
| **PPMI**        | PD            | Imaging, biospecimens | [PPMI](https://www.ppmi-info.org) |
| **GENFI**       | FTD/ALS       | Genetics, imaging | [GENFI](https://www.genfi.org) |
| **DPUK**        | Multi-NDD     | Lifestyle, genetics | [DPUK](https://www.dementiasplatform.uk) |
| **PRION Registry** | Prion Diseases | Clinical, genetic | [PRION Registry](https://prionregistry.org) |
| **UK Biobank**  | All NDDs      | Population-wide data | [UK Biobank](https://www.ukbiobank.ac.uk) |

## Implementation Strategy
Neuromarker will be implemented through:

1. **APIs for real-time biomarker data integration** from external repositories.
2. **Harmonization pipelines** to ensure biomarker standardization.
3. **Federated learning models** for **privacy-preserving biomarker training**.

## Conclusion: A Unified Neurodegenerative Disease Ontology
Neuromarker **extends CADRO** into a **comprehensive, AI-ready biomarker ontology** for **neurodegenerative disease research, biomarker discovery, and clinical decision support**.

### 🔗 **Get Involved**
- GitHub Repository: [Neurodiagnoses](https://github.com/Fundacion-de-Neurociencias/neurodiagnoses)
- eBrains Collaboration: [Neurodiagnoses eBrains](https://wiki.eBrains.eu/bin/view/Collabs/neurodiagnoses/)
